| Product Code: ETC344049 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The renal denervation market in the UK is driven by the increasing prevalence of hypertension and related cardiovascular diseases. This minimally invasive procedure targets nerves in the renal arteries to reduce blood pressure. The market is bolstered by advancements in medical technology and growing awareness of treatment options. The development of clinical trials and obtaining regulatory approvals play significant roles in market expansion.
In the UK, the renal denervation market addresses hypertension treatment through minimally invasive procedures. As a potential therapy for resistant hypertension, renal denervation techniques are gaining attention for their efficacy in lowering blood pressure.
The UK renal denervation market faces challenges related to the high costs of the procedure and the need for clinical validation to demonstrate its efficacy. Regulatory approvals and the competition from alternative treatments for hypertension also pose significant hurdles for market growth.
In the UK Renal Denervation market, government policies focus on healthcare innovation, patient safety, and regulatory compliance. Regulatory frameworks ensure clinical efficacy and safety standards for renal denervation devices used in treating hypertension and related conditions. Policies support clinical research and development in medical device technologies to advance treatment outcomes and patient care. Healthcare policies aim to expand access to innovative therapies through reimbursement schemes and healthcare system integration. Trade policies facilitate international collaboration in medical research and technology adoption, ensuring market competitiveness and patient access to cutting-edge renal denervation therapies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Renal Denervation Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Renal Denervation Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Renal Denervation Market - Industry Life Cycle |
3.4 United Kingdom (UK) Renal Denervation Market - Porter's Five Forces |
3.5 United Kingdom (UK) Renal Denervation Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 United Kingdom (UK) Renal Denervation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension and related disorders in the UK |
4.2.2 Growing adoption of minimally invasive procedures for hypertension treatment |
4.2.3 Rising geriatric population in the UK requiring renal denervation procedures |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for medical devices in the UK |
4.3.2 Limited awareness and understanding of renal denervation among patients and healthcare providers in the UK |
5 United Kingdom (UK) Renal Denervation Market Trends |
6 United Kingdom (UK) Renal Denervation Market, By Types |
6.1 United Kingdom (UK) Renal Denervation Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Renal Denervation Market Revenues & Volume, By Technology, 2021-2031F |
6.1.3 United Kingdom (UK) Renal Denervation Market Revenues & Volume, By Radiofrequency based, 2021-2031F |
6.1.4 United Kingdom (UK) Renal Denervation Market Revenues & Volume, By Ultrasound based, 2021-2031F |
6.1.5 United Kingdom (UK) Renal Denervation Market Revenues & Volume, By Micro-Infusion based, 2021-2031F |
7 United Kingdom (UK) Renal Denervation Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Renal Denervation Market Export to Major Countries |
7.2 United Kingdom (UK) Renal Denervation Market Imports from Major Countries |
8 United Kingdom (UK) Renal Denervation Market Key Performance Indicators |
8.1 Number of renal denervation procedures performed annually in the UK |
8.2 Adoption rate of renal denervation technology by hospitals and healthcare facilities in the UK |
8.3 Average waiting time for patients to undergo renal denervation procedures in the UK |
8.4 Number of clinical trials and research studies on renal denervation conducted in the UK |
8.5 Patient satisfaction rates post renal denervation procedures in the UK |
9 United Kingdom (UK) Renal Denervation Market - Opportunity Assessment |
9.1 United Kingdom (UK) Renal Denervation Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 United Kingdom (UK) Renal Denervation Market - Competitive Landscape |
10.1 United Kingdom (UK) Renal Denervation Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Renal Denervation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |